Current research continues to investigate Cagrilintides pharmacology, receptor signaling, long-term safety profile, and potential applications across obesity, metabolic disorders, appetite regulation, and combination peptide therapies
If youre not comfortable with traditional needles, its worth knowing about alternatives that can make your treatment easier
What insurance typically covers FDA-approved peptides for approved indications: Semaglutide (Ozempic) for type 2 diabetes: Often covered Semaglutide (Wegovy) for obesity: Sometimes covered with restrictions Tirzepatide (Mounjaro) for type 2 diabetes: Often covered Tirzepatide (Zepbound) for obesity: Limited coverage What coverage looks like: Prior authorization typically required Documentation of failed dietary interventions BMI thresholds for weight loss indications Co-pays still substantial ($100-500 monthly) What insurance doesn't cover The vast majority of peptide therapy falls outside insurance coverage: Compounded peptides (BPC-157, TB-500, most growth hormone peptides) Anti-aging applications even for FDA-approved drugs Performance enhancement uses Off-label applications These costs are entirely out-of-pocket for most patients
For gut-specific protocols, a cycle of 46 weeks is usually sufficient, followed by a 24 week break
